Risk factors for invasive candidiasis in infants >1500g birth weight

Pediatric Infectious Disease Journal

Volumn 32, Issue 3, 2013, Pages 222-226

  Lee, Jan Hau ^a,b   Hornik, Christoph P ^a   Benjamin Jr , Daniel K ^a   Herring, Amy H ^c   Clark, Reese H ^d   Cohen Wolkowiez, Michael ^a   Smith, P Brian ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b KK WOMEN'S AND CHILDREN'S HOSPITAL   (Singapore)

^c University of North Carolina at Chapel Hill   (United States)

^d PEDIATRIX MEDICAL GROUP   (United States)

Author keywords

Candidemia; Candidiasis; Neonatal intensive care unit; Neonates

Indexed keywords

ANTIFUNGAL AGENT;

ARTICLE; ARTIFICIAL VENTILATION; BIRTH WEIGHT; BLADDER CATHETERIZATION; BLOOD CULTURE; CANDIDA; CENTRAL VENOUS CATHETER; CEREBROSPINAL FLUID CULTURE; COHORT ANALYSIS; COMORBIDITY; EXTREMELY LOW BIRTH WEIGHT; GESTATIONAL AGE; HUMAN; HUMAN TISSUE; INCIDENCE; INFANT; INFANT MORTALITY; INFECTION PREVENTION; INFECTION RISK; INVASIVE CANDIDIASIS; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN INTENSIVE CARE; NONHUMAN; OUTCOME ASSESSMENT; PREMATURITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; THROMBOCYTE COUNT; THROMBOCYTOPENIA; URINE CULTURE; VAGINAL DELIVERY;

ANTI-BACTERIAL AGENTS; BIRTH WEIGHT; BLOOD; CANDIDIASIS, INVASIVE; CEREBROSPINAL FLUID; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; RISK FACTORS; TREATMENT OUTCOME; URINE;

EID: 84876293736     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3182769603     Document Type: Article

References (31)

1. Downey LC, Smith PB, Benjamin DK Jr. Risk factors and prevention of late-onset sepsis in premature infants. Early Hum Dev. 2010;86(suppl 1):7-12.
2. Smith PB, Morgan J, Benjamin JD, et al. Excess costs of hospital care associated with neonatal candidemia. Pediatr Infect Dis J. 2007;26:197-200.
3. Benjamin DK Jr, Stoll BJ, Fanaroff AA, et al.; National Institute of Child Health and Human Development Neonatal Research Network. Neonatal candidiasis among extremely low birth weight infants: risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 months. Pediatrics. 2006;117:84-92.
4. Stoll BJ, Hansen NI, Adams-Chapman I, et al.; National Institute of Child Health and Human Development Neonatal Research Network. Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. JAMA. 2004;292:2357-2365.
5. Wynn JL, Benjamin DK Jr, Benjamin DK, et al. Very late onset infections in the neonatal intensive care unit. Early Hum Dev. 2012;88:217-225.
6. Benjamin DK Jr, Ross K, McKinney RE Jr, et al. When to suspect fungal infection in neonates: A clinical comparison of Candida albicans and Candida parapsilosis fungemia with coagulase-negative staphylococcal bacteremia. Pediatrics. 2000;106:712-718.
7. Greenberg RG, Benjamin DK Jr, Gantz MG, et al.; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Empiric antifungal therapy and outcomes in extremely low birth weight infants with invasive candidiasis. J Pediatr. 2012;161: 264-269.e2.
8. Kaufman D, Boyle R, Hazen KC, et al. Fluconazole prophylaxis against fungal colonization and infection in preterm infants. N Engl J Med. 2001;345:1660-1666.
9. Manzoni P, Stolfi I, Pugni L, et al.; Italian Task Force for the Study and Prevention of Neonatal Fungal Infections; Italian Society of Neonatology. A multicenter, randomized trial of prophylactic fluconazole in preterm neonates. N Engl J Med. 2007;356:2483-2495.
10. Cotten CM, McDonald S, Stoll B, et al.; National Institute for Child Health and Human Development Neonatal Research Network. The association of third-generation cephalosporin use and invasive candidiasis in extremely low birth-weight infants. Pediatrics. 2006;118:717-722.
11. Benjamin DK Jr, DeLong ER, Steinbach WJ, et al. Empirical therapy for neonatal candidemia in very low birth weight infants. Pediatrics. 2003;112(3 Pt 1):543-547.
12. Rabalais GP, Samiec TD, Bryant KK, et al. Invasive candidiasis in infants weighing more than 2500 grams at birth admitted to a neonatal intensive care unit. Pediatr Infect Dis J. 1996;15:348-352.
13. Feja KN, Wu F, Roberts K, et al. Risk factors for candidemia in critically ill infants: a matched case-control study. J Pediatr. 2005;147:156-161.
14. Badran EF, Al Baramki JH, Al Shamyleh A, et al. Epidemiology and clinical outcome of candidaemia among Jordanian newborns over a 10-year period. Scand J Infect Dis. 2008;40:139-144.
15. Benjamin DK Jr, Stoll BJ, Gantz MG, et al.; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Neonatal candidiasis: epidemiology, risk factors, and clinical judgment. Pediatrics. 2010;126:e865-e873.
16. Saiman L, Ludington E, Pfaller M, et al. Risk factors for candidemia in neonatal intensive care unit patients. The National Epidemiology of Mycosis Survey study group. Pediatr Infect Dis J. 2000;19:319-324.
17. Saiman L, Ludington E, Dawson JD, et al.; National Epidemiology of Mycoses Study Group. Risk factors for Candida species colonization of neonatal intensive care unit patients. Pediatr Infect Dis J. 2001;20:1119-1124.
18. Linder N, Levit O, Klinger G, et al. Risk factors associated with candidae-mia in the neonatal intensive care unit: a case-control study. J Hosp Infect. 2004;57:321-324.
19. Shetty SS, Harrison LH, Hajjeh RA, et al. Determining risk factors for candidemia among newborn infants from population-based surveillance: Baltimore, Maryland, 1998-2000. Pediatr Infect Dis J. 2005;24:601-604.
20. Zaoutis TE, Heydon K, Localio R, et al. Outcomes attributable to neonatal candidiasis. Clin Infect Dis. 2007;44:1187-1193.
21. Zaoutis TE, Argon J, Chu J, et al. The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis. Clin Infect Dis. 2005;41:1232-1239.
22. Shorr AF, Gupta V, Sun X, et al. Burden of early-onset candidemia: analysis of culture-positive bloodstream infections from a large U.S. database. Crit Care Med. 2009;37:2519-2526; quiz 2535.
23. Lee BE, Cheung PY, Robinson JL, et al. Comparative study of mortality and morbidity in premature infants (birth weight, < 1,250g) with candidemia or candidal meningitis. Clin Infect Dis. 1998;27:559-565.
24. Blyth CC, Chen SC, Slavin MA, et al.; Australian Candidemia Study. Not just little adults: candidemia epidemiology, molecular characterization, and antifungal susceptibility in neonatal and pediatric patients. Pediatrics. 2009;123:1360-1368.
25. Stoll BJ, Hansen N, Fanaroff AA, et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics. 2002;110(2 Pt 1):285-291.
26. Weston EJ, Pondo T, Lewis MM, et al. The burden of invasive early-onset neonatal sepsis in the United States, 2005-2008. Pediatr Infect Dis J. 2011;30:937-941.
27. Stoll BJ, Hansen NI, Sanchez PJ, et al.; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Early onset neonatal sepsis: the burden of group B Streptococcal and E. coli disease continues. Pediatrics. 2011;127:817-826.
28. Lannering B, Larsson LE, Rojas J, et al. Early onset group B streptococcal disease. Seven year experience and clinical scoring system. Acta Paediatr Scand. 1983;72:597-602.
29. Philips JB 3rd, Dickman HM, Resnick MB, et al. Characteristics, mortality, and outcome of higher-birth weight infants who require intensive care. Am J Obstet Gynecol. 1984;149:875-879.
30. Lian WB, Yeo CL, Ho LY Two-year outcome of normal-birth-weight infants admitted to a Singapore neonatal intensive care unit. Ann Acad Med Singap. 2002;31:199-205.
31. Mahieu LM, Van Gasse N, Wildemeersch D, et al. Number of sites of perinatal Candida colonization and neutropenia are associated with nosocomial candidemia in the neonatal intensive care unit patient. Pediatr Crit Care Med. 2010;11:240-245.